CD8þ T-cell-mediated pulmonary immunopathology in respiratory virus infection is mediated in large part by antigen-specific TNF-a expression by antiviral effector T cells, which results in epithelial chemokine expression and inflammatory infiltration of the lung. To further define the signaling events leading to lung epithelial chemokine production in response to CD8 þ T-cell antigen recognition, we expressed the adenoviral 14.7K protein, a putative inhibitor of TNF-a signaling, in the distal lung epithelium, and analyzed the functional consequences. Distal airway epithelial expression of 14.7K resulted in a significant reduction in lung injury resulting from severe influenza pneumonia. In vitro analysis demonstrated a significant reduction in the expression of an important mediator of injury, CCL2, in response to CD8 þ T-cell recognition, or to TNF-a. The inhibitory effect of 14.7K on CCL2 expression resulted from attenuation of NF-kB activity, which was independent of Ik-Ba degradation or nuclear translocation of the p65 subunit. Furthermore, epithelial 14.7K expression inhibited serine phosphorylation of Akt, GSK-3b, and the p65 subunit of NF-kB, as well as recruitment of NF-kB for DNA binding in vivo. These results provide insight into the mechanism of 14.7K inhibition of NF-kB activity, as well as further elucidate the mechanisms involved in the induction of T-cell-mediated immunopathology in respiratory virus infection.